242
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Functional significance of the rare rs35667974 IFIH1 gene polymorphism, associated with multiple autoimmune diseases, using a structural biological approach

, , &
Pages 455-461 | Received 17 Feb 2022, Accepted 06 Jul 2022, Published online: 02 Aug 2022

References

  • Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet. 2009;10(1):43–55.
  • Gregersen PK, Olsson L. Recent advances in the genetics of autoimmune disease. Annu Rev Immunol. 2009;27:363–391.
  • Del Toro Duany Y, Wu B, Hur S. MDA5 – filament, dynamics and disease. Curr Opin Virol. 2015;12:20–25.
  • Sohn J, Hur S. Filament assemblies in foreign nucleic acid sensors. Curr Opin Struct Biol. 2016;37:134–144.
  • Rice GI, Del Toro Duany Y, Jenkinson EM, et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet. 2014;46(5):503–509.
  • Colli ML, Moore F, Gurzov EN, et al. MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic b-cell responses to the viral by-product double-stranded RNA. Hum Mol Genet. 2010;19(1):135–146.
  • Crow YJ. Type I interferonopathies: a novel set of inborn errors of immunity. Ann N Y Acad Sci. 2011;1238:91–98.
  • Smyth DJ, Cooper JD, Bailey R, et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet. 2006;38(6):617–619.
  • Nejentsev S, Walker N, Riches D, et al. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science. 2009;324(5925):387–389.
  • Li Y, Liao W, Cargill M, et al. Carriers of rare missense variants in IFIH1 are protected from psoriasis. J Invest Dermatol. 2010;130(12):2768–2772.
  • Budu-Aggrey A, Bowes J, Stuart PE, et al. A rare coding allele in IFIH1 is protective for psoriatic arthritis. Ann Rheum Dis. 2017;76(7):1321–1324.
  • Campalani E, Barker JNWN. The clinical genetics of psoriasis. Curr Genomics. 2005;6(1):51–60.
  • Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445(7130):866–873.
  • Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263–271.
  • Insel RA, Dunne JL, Atkinson MA, et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the endocrine society, and the American Diabetes Association. Diabetes Care. 2015;38(10):1964–1974.
  • Dahlquist G, Frisk G, Ivarsson SA, et al. Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM. Diabetologia. 1995;38(11):1371–1373.
  • Kolb H, Pozzilli P. Cow’s milk and type 1 diabetes: the gut immune system deserves attention. Immunol Today. 1999;20(3):108–110.
  • Onengut-Gumuscu S, Chen WM, Burren O, et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for co-localization of causal variants with lymphoid gene enhancers. Nat Genet. 2015;47(4):381–386.
  • Li YR, Li J, Zhao SD, et al. Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases. Nat Med. 2015;21(9):1018–1027.
  • Haroon NN, Paterson JM, Li P, et al. Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Ann Intern Med. 2015;163(6):409–416.
  • Jiao DM, Chang QJ, Li P. Changes in serum levels of type-III interferons in ankylosing spondylitis treated with tumor necrosis factor-alpha inhibitors. Arch Rheumatol. 2019;34(1):9–17.
  • Vanaki N, Aslani S, Jamshidi A, et al. Role of innate immune system in the pathogenesis of ankylosing spondylitis. Biomed Pharmacother. 2018;105:130–143.
  • Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369(9573):1627–1640.
  • Wagner J, Sim WH, Lee KJ, et al. Current knowledge and systematic review of viruses associated with Crohn’s disease. Rev Med Virol. 2013;23(3):145–171.
  • Shigemoto T, Kageyama M, Hirai R, et al. Identification of loss of function mutations in human genes encoding RIG-I and MDA5: Implications for resistance to type I diabetes. J Biol Chem. 2009;284(20):13348–13354.
  • Looney BM, Xia CQ, Concannon P, et al. Effects of type 1 diabetes-associated IFIH1 polymorphisms on MDA5 function and expression. Curr Diab Rep. 2015;15(11):96.
  • Wang JP, Cerny A, Asher DR, et al. MDA5 and MAVS mediate type I interferon responses to coxsackie B virus. J Virol. 2010;84(1):254–260.
  • Hato SV, Ricour C, Schulte BM, et al. The mengovirus leader protein blocks interferon-alpha/beta gene transcription and inhibits activation of interferon regulatory factor 3. Cell Microbiol. 2007;9(12):2921–2930.
  • UniProt consortium: the universal protein resource (UniProt). Nucleic Acids Res. 2008;36(Database issue):D190–D195.
  • Altschul SF, Madden TL, Schäffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25(17):3389–3402.
  • Rangwala SH, Kuznetsov A, Ananiev V, et al. Accessing NCBI data using the NCBI sequence viewer and genome data viewer (GDV). Genome Res. 2021;31(1):159–169.
  • Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res. 2000;28(1):235–242.
  • Schrödinger L, DeLano W. Schrödinger release 2017-1: Pymol V2. New York (NY): Schrödinger, LLC, 2017.
  • Waterhouse A, Bertoni M, Bienert S, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296–W303.
  • Brisse Morgan B, Hinh L. Comparative structure and function analysis of the RIG-I-like receptors: RIG-I and MDA5. Front Immunol. 2019;10:1586.
  • Yu Q, Qu K, Modis Y. Cryo-EM structures of MDA5-dsRNA filaments at different stages of ATP hydrolysis. Mol Cell. 2018;72(6):999–1012.
  • Wu B, Peisley A, Richards C, et al. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell. 2013;152(1–2):276–289.
  • Bergamaschi L, Ban M, Leone MA, et al. No evidence of association of the rare nsSNP rs35667974 in IFIH1 with multiple sclerosis. J Neuroimmunol. 2010;221(1–2):112–114.
  • Downes K, Pekalski M, Angus KL, et al. Reduced expression of IFIH1 is protective for type 1 diabetes. PLoS One. 2010;5(9):e12646.
  • Seth RB, Sun L, Ea CK, et al. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 2005;122(5):669–682.
  • Prens EP, Kant M, van Dijk G, et al. IFN-alpha enhances poly-IC responses in human keratinocytes by inducing expression of cytosolic innate RNA receptors: relevance for psoriasis. J Invest Dermatol. 2008;128(4):932–938.
  • Reder AT, Feng X. How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms. J Interferon Cytokine Res. 2014;34(8):589–599.
  • Hong J, Tejada-Simon MV, Rivera VM, et al. Anti-viral properties of interferon beta treatment in patients with multiple sclerosis. Mult Scler. 2002;8(3):237–242.
  • Panitch HS. Influence of infection on exacerbations of multiple sclerosis. Ann Neurol. 1994;36(S1):S25–S28.
  • Witsø E, Tapia G, Cinek O, et al. Polymorphisms in the innate immune IFIH1 gene, frequency of enterovirus in monthly fecal samples during infancy, and islet autoimmunity. PLoS One. 2011;6(11):e27781.
  • Cinek O, Tapia G, Witsø E, et al. Enterovirus RNA in peripheral blood may be associated with the variants of rs1990760, a common type 1 diabetes associated polymorphism in IFIH1. PLoS One. 2012;7(11):e48409.
  • Chistiakov DA, Voronova NV, Savost’Anov KV, et al. Loss-of function mutations E6 27X and I923V of IFIH1 are associated with lower poly(I:C)-induced interferon-beta production in peripheral blood mononuclear cells of type 1 diabetes patients. Hum Immunol. 2010;71(11):1128–1134.
  • Liu S, Wang H, Jin Y, et al. IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. Hum Mol Genet. 2009;18(2):358–365.
  • Fry L, Baker BS. Triggering psoriasis: the role of infections and medications. Clin Dermatol. 2007;25(6):606–615.
  • Dand N, Mucha S, Tsoi LC, et al. Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling. Hum Mol Genet. 2017;26(21):4301–4313.
  • Cen H, Wang W, Leng R-X, et al. Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Autoimmunity. 2013;46(7):455–462.
  • Rydzewska M, Góralczyk A, Joanna Gościk J, et al. Analysis of chosen polymorphisms rs2476601 a/G – PTPN22, rs1990760 C/T – IFIH1, rs179247 a/G – TSHR in pathogenesis of autoimmune thyroid diseases in children. Autoimmunity. 2018;51(4):183–190.
  • Yang H, Wang Z, Xu K, et al. IFIH1 gene polymorphisms in type 1 diabetes: genetic association analysis and genotype-phenotype correlation in Chinese Han population. Autoimmunity. 2012;45(3):226–232.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.